3Merton RK. Theoretical Sociology [M]. New York: The New York Press, 1967.
4Gray JV, Roth AV, Tomlin 13. Quality risk in contract manufacturing: Evidence from the U.S. drug industry [J]. Management Sci, 2008, 55 (1) : 1-37.
5Lansdowne ZF. Risk matrix: an approach for prioritizing risks and tracking risk mitigation progress [A]. Proceedings of the 30th annual project management institute 1999 seminars & symposium [C]. Philadelphia. USA, 1999.
6Japan Pharmaceutical Manufacturers Association, Pharmaceutical Administration and Regulations in Japan [M].日本:日本制药工业协会,2011.
9SHIMAZAWA R, IKEDA M. Japanese regulatory system for ap- proval of off-label drug use : evaluation of safety and effectiveness in literature-based applications [ J ]. Clin Ther, 2012, 34 ( 10 ) : 2104 - 2116.
